Carbonic Anhydrase Inhibitors
"Carbonic Anhydrase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.
| Descriptor ID |
D002257
|
| MeSH Number(s) |
D27.505.519.389.200
|
| Concept/Terms |
Carbonic Anhydrase Inhibitors- Carbonic Anhydrase Inhibitors
- Inhibitors, Carbonic Anhydrase
- Carbonate Dehydratase Inhibitors
- Inhibitors, Carbonate Dehydratase
- Carboxyanhydrase Inhibitors
- Inhibitors, Carboxyanhydrase
|
Below are MeSH descriptors whose meaning is more general than "Carbonic Anhydrase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Carbonic Anhydrase Inhibitors".
This graph shows the total number of publications written about "Carbonic Anhydrase Inhibitors" by people in this website by year, and whether "Carbonic Anhydrase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 2 | 1 | 3 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbonic Anhydrase Inhibitors" by people in Profiles.
-
Arbabi A, Bao X, Shalaby WS, Razeghinejad R. Systemic side effects of glaucoma medications. Clin Exp Optom. 2022 03; 105(2):157-165.
-
Guimaraes TAC, Capasso JE, Levin AV. Paradoxical response to carbonic anhydrase inhibitors in patients with intraretinal cystoid spaces. Ophthalmic Genet. 2019 06; 40(3):213-218.
-
Rahimy E, Ying GS, Pan W, Hsu J. EFFECT OF INTRAOCULAR PRESSURE-LOWERING MEDICATIONS ON NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATMENT OUTCOMES IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENT TRIALS. Retina. 2019 Apr; 39(4):636-647.
-
Su D, Obeid A, Hsu J. Topical Aqueous Suppression and Closure of Idiopathic Full-Thickness Macular Holes. Ophthalmic Surg Lasers Imaging Retina. 2019 02 01; 50(2):e38-e43.
-
Lingao MD, Ganesh A, Karthikeyan AS, Al Zuhaibi S, Al-Hosni A, Al Khayat A, Capasso J, Trumler AA, Stroh E, Al Shekaili H, Cater JR, Levin AV. Macular cystoid spaces in patients with retinal dystrophy. Ophthalmic Genet. 2016 12; 37(4):377-383.
-
Cordovez JA, Traboulsi EI, Capasso JE, Sadagopan KA, Ganesh A, Rychwalski PJ, Neely KA, Brodie SE, Levin AV. Retinal Dystrophy with Intraretinal Cystoid Spaces Associated with Mutations in the Crumbs Homologue (CRB1) Gene. Ophthalmic Genet. 2015; 36(3):257-64.
-
Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012 Apr 24; 78(17):1337-45.
-
de Barros DS, Navarro JB, Mantravadi AV, Siam GA, Gheith ME, Tittler EH, Baez KA, Martinez SM, Spaeth GL. The early flat anterior chamber after trabeculectomy: a randomized, prospective study of 3 methods of management. J Glaucoma. 2009 Jan; 18(1):13-20.
-
Mathews MK, Sergott RC, Savino PJ. Pseudotumor cerebri. Curr Opin Ophthalmol. 2003 Dec; 14(6):364-70.
-
Schuman JS. Short- and long-term safety of glaucoma drugs. Expert Opin Drug Saf. 2002 Jul; 1(2):181-94.